These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 476013)

  • 1. A genetic variant of factor IX with decreased capacity for Ca2+ binding.
    Bertina RM; Veltkamp JJ
    Br J Haematol; 1979 Aug; 42(4):623-35. PubMed ID: 476013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor IX Zutphen. A genetic variant of blood coagulation factor IX with an abnormally high molecular weight.
    Bertina RM; Van Der Linden IK
    J Lab Clin Med; 1982 Nov; 100(5):695-704. PubMed ID: 7130828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The abnormal factor IX of hemophilia B+ variants.
    Bertina RM; Veltkamp JJ
    Thromb Haemost; 1978 Oct; 40(2):335-49. PubMed ID: 734633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two allotypes of factor IX present in haemophilia B.
    Ljung R; Wallmark A; Nilsson IM
    Scand J Haematol; 1986 Nov; 37(5):411-6. PubMed ID: 3810038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective propeptide processing and abnormal activation underlie the molecular pathology of factor IX Troed-y-Rhiw.
    Liddell MB; Lillicrap DP; Peake IR; Bloom AL
    Br J Haematol; 1989 Jun; 72(2):208-15. PubMed ID: 2788012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on precursor proteins PIVKA-II, -IX, and -X in the plasma of patients with 'hemorrhagic disease of the newborn'.
    Fujimura Y; Okubo Y; Sakai T; Sugimoto M; Takase T; Yoshioka A; Fukui H
    Haemostasis; 1984; 14(2):211-7. PubMed ID: 6735278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Electroimmunoassay of human coagulation factor IX in the detection of variants of haemophilia B.
    Orstavik K; Osterud B
    Thromb Diath Haemorrh; 1975 Sep; 34(1):322-3. PubMed ID: 1188733
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic site.
    Usharani P; Warn-Cramer BJ; Kasper CK; Bajaj SP
    J Clin Invest; 1985 Jan; 75(1):76-83. PubMed ID: 3965513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of factor IX BM. Difference of cleavage sites by factor XIa and Ca2+ in factor IX Kashihara, factor IX Nagoya and factor IX Niigata.
    Yoshioka A; Ohkubo Y; Nishimura T; Tanaka I; Fukui H; Ogata K; Kamiya T; Takahashi H
    Thromb Res; 1986 Jun; 42(5):595-604. PubMed ID: 3487139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Presence of inactive factor ix in variants of hemophilia, type B, and in carriers of hemophilia B].
    Elodi S
    Minerva Med; 1975 Jun; 66(42):2037-43. PubMed ID: 1138213
    [No Abstract]   [Full Text] [Related]  

  • 12. Another genetic variant of haemophilia B: haemophilia B Leyden.
    Veltkamp JJ; Meilof J; Remmelts HG; van der Vlerk D; Loeliger EA
    Scand J Haematol; 1970; 7(2):82-90. PubMed ID: 5450691
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological heterogeneity of haemophilia B: a multicentre study of 98 kindreds.
    Parekh VR; Mannucci PM; Ruggeri ZM
    Br J Haematol; 1978 Dec; 40(4):643-55. PubMed ID: 103564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants of haemophilia B detected by immunoradiometric assay: implications for prenatal diagnosis.
    Ljung R; Holmberg L
    Pediatr Res; 1982 Mar; 16(3):256-8. PubMed ID: 7063280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of carriers of haemophilia B.
    Orstavik KH; Veltkamp JJ; Bertina RM; Hermans J
    Br J Haematol; 1979 Jun; 42(2):293-301. PubMed ID: 465373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of heterogeneity of haemophilia B for the detection of carriers.
    Panicucci F; Sagripanti A; Conte B; Pinori E; Vispi M; Lecchini L
    Haemostasis; 1980; 9(5):310-8. PubMed ID: 6157611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemophilia B caused by a missense mutation in the prepeptide sequence of factor IX.
    Green PM; Mitchell VE; McGraw A; Goldman E; Giannelli F
    Hum Mutat; 1993; 2(2):103-7. PubMed ID: 8318985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying hemophilia B carriers: Utility of aPTT, factor IX levels and ratios of factor IX to other Vitamin K dependent factors.
    Shu M; Malcolmson C; Bosch A; Markovic T; Wakefield C; Bouskill V; Carcao M
    Haemophilia; 2024 Jul; 30(4):1003-1009. PubMed ID: 38924261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in bleeding phenotype in Amish carriers of haemophilia B with the 31008 C-->T mutation.
    Sharathkumar A; Hardesty B; Greist A; Salter J; Kerlin B; Heiman M; Sulkin M; Shapiro A
    Haemophilia; 2009 Jan; 15(1):91-100. PubMed ID: 18721150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of factor IX allotypes for carrier identification in haemophilia B.
    Wallmark A; Ljung R; Nilsson IM
    Br J Haematol; 1987 Dec; 67(4):427-32. PubMed ID: 3426960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.